Minority Squeeze-Out and Appraisal Rights

When a minority shareholder receives notice of a merger that will cash them out of their holdings, they face a critical choice: accept the offered price or exercise appraisal rights, demanding that a court determine fair value. This remedy protects minorities against low-ball “squeeze-out” offers in which controlling shareholders or a buyer force non-shareholders to exit at an unfavorable price. The appraisal process is lengthy and uncertain, but it stands as the minority’s legal shield against unfair valuation.

The mechanics of a squeeze-out

A squeeze-out merger occurs when a controlling shareholder (often the founder or a private equity buyer) or an external acquirer uses a merger to force minority shareholders into a cash payout at a price set by the board or majority vote.

The controlling party structures the merger so that their shares (or 100% of the acquired company) merge with a subsidiary, and minority shareholders automatically receive cash equal to the agreed merger price, typically $X per share. Minorities have no choice: the merger is either approved by board vote (with interested directors abstaining) or a shareholder vote is held (where the controlling party votes yes, outnumbering minorities).

The squeeze-out is legal. Delaware corporate law and most state laws permit majority shareholders to cash out minorities via merger. The issue is valuation: is $X actually fair to the minority, or did the majority negotiate a low price?

Appraisal rights: the statutory escape hatch

To protect minorities, all U.S. states grant appraisal rights (sometimes called “dissenters’ rights”). A shareholder who dissents from a merger can demand appraisal—a court-supervised valuation of fair value. The steps are:

1. Demand notice: Before or shortly after the merger vote, the shareholder files a written demand for appraisal (timing rules vary; Delaware allows 20–30 days).
2. Pre-trial process: The company or buyer appraiser and the shareholder appraisers exchange valuation opinions, evidence, and expert reports.
3. Trial: A judge (or jury in some states) hears testimony from opposing valuation experts and decides fair value.
4. Award: The shareholder receives the court’s determination of fair value, not the merger price, minus any cash they already received, plus interest accrued.

The key protection: the court sets value independently, ignoring the merger price that may have been negotiated by interested parties.

Standards for fair value

States define fair value differently. Delaware (the most common incorporation state) requires “intrinsic value”—the company’s value as an ongoing business, not affected by the merger synergies or deal premium. This is contrasted with appraisal value (the price the market would pay) or going-concern value.

In practice, “intrinsic value” means courts typically exclude:

• Synergies the buyer realizes: If the buyer merges the target into a larger firm and cuts redundancies, those cost savings don’t boost the target’s “fair value” as it stood pre-merger. The buyer’s synergies are the buyer’s gain, not the target’s intrinsic value.
• Control premiums: If the buyer paid a control premium (say, 30% above market price) because they controlled the post-merger entity, that premium doesn’t inflate the target’s intrinsic value. The court looks to value a minority stake, not a control stake.
• Illiquidity discounts: Conversely, courts typically reject arguments that a minority discount should reduce fair value. The appraisal remedy is deemed to compensate for illiquidity already.

Fair value is usually calculated as the standalone business value, using discounted cash flow (DCF), comparable-company multiples, or precedent transactions.

Valuation methods in appraisal litigation

Both sides commission expert appraisers. The company’s appraiser might value the target at $50/share; the minority’s appraiser might say $75/share. The judge or jury weighs testimony, cross-examination, and the methodology each expert used.

DCF approach: Project future free cash flows for 5–10 years, then apply a terminal growth rate and discount rate. This is sensitive to assumptions: a 1% difference in discount rate can swing valuation 20%+.

Comparable-company multiples: Identify publicly traded peers and apply their revenue, EBITDA, or earnings multiples to the target’s financials. For instance, if similar companies trade at 12× EBITDA and the target generates $100M EBITDA, fair value is $1.2B.

Asset-based approach: Total up tangible and intangible assets, subtract liabilities. Less common for ongoing businesses, but used when the target is capital-intensive or land-rich.

Judges often “cherry-pick” the best elements of each approach, or weight them differently than experts suggest. The resulting verdict is rarely the high or low end; it’s often somewhere in the middle.

Economic risks and costs of appraisal

Appraisal is not a free put option. The shareholder must fund legal costs (often $500K–$2M for a trial), hire expert appraisers, and wait 1–3 years for a verdict. If the court awards less than the merger price, the shareholder loses money (net of the difference).

Example: A merger offers $50/share. The shareholder appraises, hoping for $70/share. The court awards $55/share. The shareholder received $50 at closing, plus $5 more per share; but they paid $1M in legal and expert fees on, say, 100,000 shares ($100M total holding). On a $500K investment position, that $100K gain (net) is eaten by fees.

Conversely, if the court awards $65/share, the shareholder gains $15/share, which more than covers costs. This asymmetry means appraisal is often rational only for large shareholders or classes of shareholders who can spread legal costs.

Also, courts sometimes reject appraisal demands on procedural grounds (failure to demand on time, waiver by voting for the merger, etc.). A shareholder may spend money preparing for appraisal only to find the court dismisses the case.

When appraisal is credible

Appraisal is most credible when:

• The merger price was negotiated at arm’s length but with a controlling shareholder benefiting differently. The court may suspect the controlling shareholder negotiated a lower price in exchange for side benefits.
• The target had strong standalone value that the buyer’s model undervalued. A mature, profitable target that the buyer is folding into itself may warrant higher fair value than the merger price suggests.
• There is no public-market reference. If the target was public and the merger price was set via an open auction, courts are more deferential. If the target was private, the appraisal process is the only pricing mechanism.
• The board process was flawed. If interested directors didn’t recuse themselves, or minority shareholders were misled, courts may lean toward appraisal as the fairness check.

Factors courts weigh in setting fair value

Beyond valuation mechanics, courts consider:

• Board diligence: Did the board solicit competing offers, hire a financial advisor, and negotiate at arm’s length? Courts respect well-process deals.
• Minority shareholder process: Did minorities have a separate vote, or a chance to block? Some states require a “majority of minority” vote to trigger appraisal; others don’t.
• Deal context: Is this a fire sale (high appraisal likelihood), a consolidation with synergies (harder to justify high appraisal), or a squeeze-out of a founder-controlled company (moderate appraisal likelihood)?
• Expert testimony credibility: Which appraiser’s DCF assumptions are more grounded? Whose comparable-company selection is more rigorous?

Variations by state

Appraisal rights vary significantly. Delaware is most restrictive: you must own stock before the merger announcement, you lose appraisal if you vote for the merger (unless the target wasn’t public), and you must demand within 20 days. California is more generous: you can appraise if you dissent, and you can work backward even after voting.

Some states grant appraisal only in fundamental transactions (mergers, dissolutions); others extend it to asset sales or charter amendments.

Corporations listed on the New York Stock Exchange or Nasdaq are excluded from appraisal rights under federal law if the stock is widely held. This protects big, public companies from appraisal litigation. But private companies and closely held public shells are fair game.

See also